It’s now almost nine years since the first CAR-T therapies, Kymriah and Yescarta, were approved by the FDA. These therapies and others have revolutionised the treatment of certain hard-to-treat blood cancers, such as ALL and some B-cell lymphomas. There was rightly huge elation at the time. CAR-Ts were a real breakthrough, offering a lifeline – […]
The World Cup kicked off this week and so did our clients, with new appointments, important clinical trial updates and major collaborations announced! The Optimum team was proud to support and attend Weatherden’s Symposium on Women’s Health yesterday, which featured a stellar line-up of speakers to explore how smarter clinical development and regulatory strategy can […]
The heatwave has been replaced by heavy showers, but June is looking bright for our clients, with huge congratulations to Ona Therapeutics for its $86.6M Series B financing and to DaltonTx for the launch of its AI-enabled drug discovery platform. Dr. Hans Eriksson is joining FundaMental Pharma’s team as CMO and Renée Aguiar-Lucander participated in […]
Last month I went to Copenhagen for the LSX Nordic conference, which was great. The metro ride from the airport to the city centre in a driverless train was a novelty for me, as tube trains on the London Underground all have drivers. I thought no more about it. What if, though, the aeroplane in […]
